SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $83,001 | -19.8% | 3,590 | -9.0% | 0.05% | -18.0% |
Q2 2023 | $103,464 | -6.8% | 3,946 | -8.5% | 0.06% | 0.0% |
Q1 2023 | $111,042 | -28.6% | 4,314 | -27.8% | 0.06% | -24.7% |
Q4 2022 | $155,488 | +5.8% | 5,978 | +16.1% | 0.08% | +37.3% |
Q3 2022 | $147,000 | +16.7% | 5,151 | +0.8% | 0.06% | +25.5% |
Q2 2022 | $126,000 | -2.3% | 5,111 | +123.4% | 0.05% | -19.0% |
Q1 2022 | $129,000 | -14.0% | 2,288 | -5.6% | 0.06% | +1.8% |
Q4 2021 | $150,000 | -10.2% | 2,425 | -8.1% | 0.06% | -21.9% |
Q3 2021 | $167,000 | -27.1% | 2,640 | -4.8% | 0.07% | -22.3% |
Q2 2021 | $229,000 | -22.4% | 2,774 | -30.8% | 0.09% | -24.8% |
Q1 2021 | $295,000 | +3.1% | 4,006 | +1.7% | 0.12% | +5.0% |
Q4 2020 | $286,000 | -16.4% | 3,940 | -45.0% | 0.12% | -33.5% |
Q3 2020 | $342,000 | 0.0% | 7,168 | -12.0% | 0.18% | +10.5% |
Q2 2020 | $342,000 | +1.8% | 8,149 | -34.5% | 0.16% | +17.4% |
Q1 2020 | $336,000 | -38.8% | 12,448 | -12.7% | 0.14% | +53.3% |
Q4 2019 | $549,000 | – | 14,253 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |